Transcription factor TBX1 overexpression induces downregulation of proteins involved in retinoic acid metabolism: A comparative proteomic analysis

Journal of Proteome Research

Volumn 8, Issue 3, 2009, Pages 1515-1526

  Caterino, Marianna ^a,b   Ruoppolo, Margherita ^a,b,c   Fulcoli, Gabriella ^d,e   Huynth, Tuong ^e   Orrù, Stefania ^a,e   Baldini, Antonio ^c,d   Salvatore, Francesco ^a,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^c TEXAS A AND M UNIVERSITY   (United States)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^e UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

DIGE; DiGeorge syndrome; Proteomics; Retinoic acid; T box containing transcription factor

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CYCLIN DEPENDENT KINASE 4; CYCLINE; DJ 1 PROTEIN; GLYCINE HYDROXYMETHYLTRANSFERASE; GLYCINE HYDROXYMETHYLTRANSFERASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN BETA 2; GUANINE NUCLEOTIDE BINDING PROTEIN BETA 3; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; HEAT SHOCK PROTEIN 90; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H1; KARYOPHERIN ALPHA; KARYOPHERIN ALPHA 2; NEUROLYSIN; NUCLEOLIN; NUCLEOPHOSMIN; ORNITHINE OXOACID AMINOTRANSFERASE; PEROXIREDOXIN 1; PYRUVATE KINASE; RETINOIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TBX1; TRANSKETOLASE; UNCLASSIFIED DRUG; VILLIN; VILLIN 2; VINCULIN; VOLTAGE DEPENDENT ANION CHANNEL 1;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DIGEORGE SYNDROME; DOWN REGULATION; GENE OVEREXPRESSION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN TARGETING; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 65249151895     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800870d     Document Type: Article

References (43)

1. Chapman, D. L.; Agulnik, I.; Hancock, S.; Silver, L. M.; Papaioan- nou, V. E. Tbx6, a mouse T-box gene implicated in paraxial mesoderm formation at gastrulation. Dev. Biol. 1996, 180, 534-542.
2. Scambler, P J. The 22q11 deletion syndromes. Hum. Mol. Genet. 2000, 9, 2421-6.
3. Yagi, H.; Furutani, Y.; Hamada, H.; Sasaki, T.; Asakawa, S.; Minoshima, S.; Ichida, F.; Joo, K.; Kimura, M.; Imamura, S.; Kamatani, N.; Momma, K.; Takao, A.; Nakazawa, M.; Shimizu, N.; Matsuoka, R. Role of TBX1 in human del22q11.2 syndrome. Lancet 2003, 362, 1366-73.
4. Paylor, R.; Glaser, B.; Mupo, A.; Ataliotis, P.; Spencer, C.; Sobotka, A.; Sparks, C.; Choi, C. H.; Oghalai, J.; Curran, S.; Murphy, K. C.; Monks, S.; Williams, N.; O'Donovan, M. C.; Owen, M. J.; Scambler, P. J.; Lindsay, E. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 7729-34.
5. Lindsay, E. A.; Baldini, A. Recovery from arterial growth delay reduces penetrance of cardiovascular defects in mice deleted for the DiGeorge syndrome region. Hum. Mol. Genet. 2001, 10, 997-1002.
6. Vitelli, F.; Morishima, M.; Taddei, I.; Lindsay, E. A.; Baldini, A. Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways. Hum. Mol. Genet. 2002, 11, 915-22.
7. Stalmans, I.; et al. VEGF: a modifier of the del22q11 (DiGeorge) syndrome? Nat. Med. 2003, 9, 173-82.
8. Jerome, L. A.; Papaioannou, V. E. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet. 2001, 3, 286-91.
9. Garg, V.; Yamagishi, C.; Hu, T.; Kathiriya, I. S.; Yamagishi, H.; Srivastava, D. Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development. Dev. Biol. 2001, 235, 62-73.
10. Vitelli, F.; Taddei, I.; Morishima, M.; Meyers, E. N.; Lindsay, E. A.; Baldini, A. A genetic link between Tbx1 and fibroblast growth factor signaling. Development 2002, 129, 4605-11.
11. Vitelli, F.; Viola, A.; Morishima, M.; Pramparo, T.; Baldini, A.; Lindsay, E. TBX1 is required for inner ear morphogenesis. Hum. Mol. Genet. 2003, 12, 2041-8.
12. Zhang, Z.; Huynh, T.; Baldini, A. Mesodermal expression o Tbx1 is necessary and sufficient for pharyngeal arch and cardiac outflow tract development. Development 2006, 133, 3587-3595.
13. Arnold, J. S.; Braunstein, E. M.; Ohyama, T.; Groves, A. K.; Adams, J. C.; Brown, M. C.; Morrow, B. E. Tissue specific roles of Tbx1 in the development of the outer, middle and inner ear, defective in 22q11DS. Hum. Mol. Genet. 2006, 15, 1629-3.
14. Lindsay, E. A.; Vitelli, F.; Su, H.; Morishima, M.; Huynh, T.; Pramparo, T.; Jurecic, V.; Ogunrinu, G.; Sutherland, H. F.; Scam- bler, P. J.; Bradley, A.; Baldini, A. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 2001, 410, 97-101.
15. Merscher, S.; Funke, B.; Epstein, J. A.; Heyer, J.; Puech, A.; Lu, M. M.; Xavier, R. J.; Demay, M. B.; Russell, R. G.; Factor, S.; Tokooya, K.; Jore, B. S.; Lopez, M.; Pandita, R. K.; Lia, M.; Carrion, D.; Xu, H.; Schorle, H.; Kobler, J. B.; Scambler, P.; Wynshaw-Boris, A.; Skoultchi, A. I.; Morrow, B. E.; Kucherlapati, R. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 2001, 104, 619-29.
16. Vitelli, F.; Zhang, Z.; Huynh, T.; Sobotka, A.; Mupo, A.; Baldini, A. Fgf8 expression in the Tbx1 domain causes skeletal abnormalities and modifies the aortic arch but not the outflow tract phenotype of Tbx1 mutants. Dev. Biol. 2006, 295, 559-70.
17. Hu, T.; Yamagishi, H.; Maeda, J.; McAnally, J.; Yamagishi, C.; Srivastava, D. Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors. Development 2004, 131, 5491-502.
18. Kelly, R. G.; Papaioannou, V. E. Visualization of outflow tract development in the absence of Tbx1 using an Fgf10 enhancer trap transgene. Dev. Dyn. 2007, 236, 821-8.
19. Xu, H.; Morishima, M.; Wylie, J. N.; Schwartz, R. J.; Bruneau, B. G.; Lindsay, E. A. Baldini ATbx1 has a dual role in the morphogenesis of the cardiac outflow tract. Development 2004, 131, 3217-27.
20. Guris, D.; Duester, G.; Papaioannou, V. E.; Imamoto, A. Dose- dependent interaction of Tbx1 and Crkl and locally aberrant RA signalling in a model of del22q11 syndrome. Dev. Cell 2006, 10, 81-92.
21. Roberts, C.; Ivins, S.; Cook, A. C.; Baldini, A.; Scambler, P. J. Cyp26 genes a1, b1 and c1 are down-regulated in Tbx1 null mice and inhibition of Cyp26 enzyme function produces a phenocopy of DiGeorge Syndrome in the chick. Hum. Mol. Genet. 2006, 15, 3394-10.
22. Baldini, A. Dissecting contiguous gene defects: TBX1. Proteomics in 2002: a year of technical development and wide-ranging applications. Curr. Opin. Genet. Dev. 2005, 15, 279-84.
23. Figeys, D. Proteomics in 2002: a year of technical development and wide-ranging applications. Anal. Chem. 2003, 75, 2981-2905.
24. Zhou, G.; Li, H.; DeCamp, D.; Chen, S.; Shu, H.; Gong, Y.; Flaig, M.; Gillespie, J. W.; Hu, N.; Taylor, P. R.; Emmert-Buck, M. R.; Liotta, LA,; Petricoin EFIII, Zhao, Y. 2D differential in-gel electro- phoresis for the identification of esophageal scans cell cancer- specific protein markers. Mol. Cell. Proteomics 2002, 1, 117-124.
25. Gharbi, S.; Gaffney, P.; Yang, A.; Zvelebil, M. J.; Cramer, R.; Waterfield, M. D.; Timms, J. F. Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol. Cell. Proteomics 2002, 1, 91-98.
26. Marouga, R.; David, S.; Hawkins, E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal. Bioanal. Chem. 2005, 382, 669-678.
27. Zhang, S. X.; Garcia-Gras, E.; Wycuff, D. R.; Marriot, S. J.; Kadeer, N.; Yu, W.; Olson, E. N.; Garry, D. J.; Parmacek, M. S.; Schwartz, R. J. Identification of direct serum-response factor gene targets during Me2SO-induced P19 cardiac cell differentiation. J. Biol. Chem. 2005, 280, 19115-26.
28. Perkins, D. N.; Pappin, D. J.; Creasy, D. M.; Cottrell, J. S. Probability- based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20, 3551-67.
29. Nowotschin, S.; Liao, J.; Gage, P. J.; Epstein, J. A.; Campione, M.; Morrow, B. E. Tbx1 affects asymmetric cardiac morphogenesis by regulating Pitx2 in secondary heart field. identification of downstream genetic pathways of Tbx1 in the second heart field. Development 2006, 133, 1565-73.
30. Mark, M.; Ghyselinck, N. B.; Chambon, P. Retinoic acid signalling in the development of branchial arches. Curr. Opin. Genet. Dev. 2004, 14, 591-598.
31. Niederreither, K.; Vermot, J.; Le Roux, I.; Schuhbaur, B.; Chambon, P.; Dolle, P. The regional pattern of retinoic acid synthesis by RALDH2 is essential for the development of posterior pharyngeal arches and the enteric nervous system. Development 2003, 130 (11), 2525-34.
32. Vermot, J.; Niederreither, K.; Garnier, J. M.; Chambon, P.; Dolle, P. Decreased embryonic retinoic acid synthesis results in a DiGeorge syndrome phenotype in newborn mice. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 1763-8.
33. Niederreither, K.; Subbarayan, V.; Dolle, P.; Chambon, P. Embryonic retinoic acid synthesis is essential for early mouse post- implantation development. Nat. Genet. 1999, 21, 346-7.
34. Niederreither, K.; Vermot, J.; Schuhbaur, B.; Chambon, P.; Dolle, P. Retinoic acid synthesis and hindbrain patterning in the mouse embryo. Development 2000, 127, 75-85.
35. Niederreither, K.; Vermot, J.; Messaddeq, N.; Schuhbaur, B.; Chambon, P.; Dolle, P. Embryonic retinoic acid synthesis is essential for heart morphogenesis in the mouse. Development 2001, 128, 1019-31.
36. Xavier-Neto, J.; Rosenthal, N.; Silva, F. A.; Matos, T. G.; Hochgreb, T.; Linhares, V. L. Retinoid signalling and cardiac anteroposterior segmentation genesis. Genesis 2001, 31, 97-104.
37. Yutzey, K. E.; Rhee, J. T.; Bader, D. Expression of the atrial-specific myosin heavy chain AMHC1 and the establishment of anteroposterior polarity in the developing chicken heart. Development 1994, 120, 871-883.
38. Liao, J.; Aggarwal, V. S.; Nowotschin, S.; Bondraev, A.; Lipner, S.; Morrow, B. E. identification of downstream genetic pathways of Tbx1 in the second heart field. Dev. Biol. 2008, 316, 524-537.
39. Kohler, T.; Prols, F.; Brand-Saberi, B. PCNA in situ hybridization: a novel and reliable tool for detection of dynamic changes in proliferative activity. Histochem. Cell Biol. 2005, 123, 315-27.
40. Wen, J.; Xia, Q.; Lu, C.; Yin, L.; Hu, J.; Gong, Y.; Yin, B.; Monzen, K.; Yuan, J.; Qiang, B.; Zhang, X.; Peng, X. Proteomic analysis of cardiomyocytes differentiation in mouse embryonic carcinoma P19CL6 cells. J. Cell. Biochem. 2007, 102, 149-60.
41. Kreuder, J.; Borkhardt, A.; Repp, R.; Pekrun, A.; Gottsche, B.; Gottschalk, U.; Reichmann, H.; Schachenmayr, W.; Schlegel, K.; Lampert, F. Brief report: inherited metabolic myopathy and hemolysis due to a mutation in aldolase A. N. Engl. J. Med. 1996, 334, 1100-4.
42. Gomes, A. V.; Zong, C.; Ping, P. Protein degradation by the 26S proteasome system in the normal and stressed myocardium. Antioxid. Redox Signaling 2006, 8, 1677-91.
43. Cammas, F.; Janoshazi, A.; Lerouge, T.; Losson, R. Dynamic and selective interactions of the transcriptional corepressor TIF1β with the heterochromatin protein HP1 isotypes during cell differentiation. Differentiation 2007, 75, 627-34.